GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Issuance of Stock

Rapid Dose Therapeutics (XCNQ:DOSE) Issuance of Stock : C$1.37 Mil (TTM As of Nov. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics Issuance of Stock?

Rapid Dose Therapeutics's Issuance of Stock for the three months ended in Nov. 2024 was C$0.48 Mil.

Rapid Dose Therapeutics's Issuance of Stock for the trailing twelve months (TTM) ended in Nov. 2024 was C$1.37 Mil.

Rapid Dose Therapeutics Issuance of Stock Historical Data

The historical data trend for Rapid Dose Therapeutics's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Issuance of Stock Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 0.90 - 0.15 1.21

Rapid Dose Therapeutics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.58 0.31 0.48

Rapid Dose Therapeutics Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Issuance of Stock
Comparable Companies
XCNQ:PHRM TSXV:GSD TSX:BCT NEOE:BMND TSXV:SBM XCNQ:MDMA TSXV:KNE XCNQ:TELI TSX:CSCI XCNQ:PREV VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
RDTCF:USA
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Website
https://www.rapid-dose.com
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
Executives
Mark Upsdell Director
Brian Howlett Director

Rapid Dose Therapeutics Headlines

No Headlines